Published in Surgery Litigation and Law Weekly, May 22nd, 2009
"CCL5 expression and invasive ability of four human breast cancer cell lines MCF-7,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.